Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-25 @ 3:26 AM
NCT ID:
NCT02490605
Eligibility Criteria:
Inclusion Criteria:
* Patients who are more than 20 years old,
* Both genders,
* Patients who present signs and symptoms of TMD identified by way of filling out the questionnaire of the RDC-TMD (Diagnostic Research Criteria) complemented by way of diagnostic imaging via an MRI of the temporomandibular joint.
* Patients who have their natural teeth, allowing for the use of partial, removable, Class-III Kennedy prostheses with small and medium spaces (up to 3 elements), having as a criteria posterior control (patients with partial, removable prostheses without presenting any type of compression marks or lesions under the structure, points of trauma indicated by redness of the mucosa, and verification of simultaneous, bilateral contacts) (Stegun; Costa, 2000).
* Patients who undergo the MRI of the temporomandibular joint at the time of the evaluation.
Exclusion Criteria:
* Patients entirely without unimaxillar and bimaxillar teeth,
* Patients with a dislocated disc without reduction,
* Patients with a history of cervical macrotraumas,
* Patients who continually use analgesics and anti-inflammatories, and/or medications that might effect their balance,
* Patients with compromised vision without corrections,
* Patients with neurological alterations,
* Patients with a history of falls,
* Patients with diabetes accompanied by sensitive neuropathies,
* Patients who complain of labyrinthitis.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
75 Years
Study:
NCT02490605
Study Brief:
Protocol Section:
NCT02490605